CNR Institutional Research Information System

CHIARINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.139
NA - Nord America 681
EU - Europa 180
SA - Sud America 176
AF - Africa 15
OC - Oceania 3
Totale 2.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 655
SG - Singapore 463
CN - Cina 310
BR - Brasile 152
HK - Hong Kong 101
VN - Vietnam 97
KR - Corea 59
FR - Francia 51
IT - Italia 44
BD - Bangladesh 22
IN - India 19
CA - Canada 15
DE - Germania 15
FI - Finlandia 14
AR - Argentina 13
IL - Israele 13
JP - Giappone 13
NL - Olanda 12
ES - Italia 5
GB - Regno Unito 5
ID - Indonesia 5
PL - Polonia 5
TR - Turchia 5
MX - Messico 4
SA - Arabia Saudita 4
SE - Svezia 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
IQ - Iraq 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
RU - Federazione Russa 2
SN - Senegal 2
AT - Austria 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 2.194
Salva come PNG Salva come JPEG
Città #
Santa Clara 321
Singapore 269
Hefei 151
Hong Kong 98
Beijing 60
San Jose 59
Seoul 59
Ho Chi Minh City 43
Lauterbourg 41
Los Angeles 38
Ashburn 35
Hanoi 24
Dallas 18
New York 15
São Paulo 14
Buffalo 11
Helsinki 11
Minamishinagawa 8
Orem 8
Bengaluru 6
Rio de Janeiro 5
Da Nang 4
Istanbul 4
Belgrade 3
Biên Hòa 3
Bologna 3
Brooklyn 3
Curitiba 3
Falkenstein 3
Frankfurt am Main 3
Maceió 3
Montreal 3
Phoenix 3
Tel Aviv 3
Thái Bình 3
Tokyo 3
Toronto 3
Volta Redonda 3
Warsaw 3
Ampang 2
Baghdad 2
Bauru 2
Belo Horizonte 2
Bishkek 2
Boston 2
Bắc Giang 2
Chennai 2
Chicago 2
Dakar 2
Denver 2
Dhaka 2
Dublin 2
Feira de Santana 2
Fortaleza 2
Hortolândia 2
Houston 2
Hải Dương 2
Johannesburg 2
Lappeenranta 2
Macaé 2
Manchester 2
Milan 2
Modena 2
Mossoró 2
Mumbai 2
Munich 2
Nha Trang 2
Nova Iguaçu 2
Nuremberg 2
Padova 2
Paracatu 2
Passos 2
Quito 2
Salvador 2
San Francisco 2
Santos 2
Seattle 2
Shanghai 2
Sofia 2
Stockholm 2
Sydney 2
São Leopoldo 2
Thái Nguyên 2
Tirana 2
Trieste 2
Uberaba 2
Vientiane 2
'Asir Region 1
Abbeville 1
Abbottabad 1
Acalanes Ridge 1
Ahmedabad 1
Alexandria 1
Amarante 1
Amman 1
Ancol 1
Ankara 1
Antofagasta 1
Anápolis 1
Aparecida d'Oeste 1
Totale 1.459
Salva come PNG Salva come JPEG
Nome #
Lamin A and Prelamin a Counteract Migration of Osteosarcoma Cells 99
The role played by wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia 87
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-?B. 77
Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model. 74
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia 74
Advances in targeting signal transduction pathways. 71
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. 68
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 60
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 60
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer. 56
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma 55
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia 53
The Cutting Edge: The Role of mTOR Signaling in Laminopathies 49
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 48
LTER Macrosito IT17-M Stazioni Di Ricerca In Antartide- Mooring B: North Central Ross Sea, Joides Basin - Antarctica 47
Therapeutic targeting of CK2 in acute and chronic leukemias 45
LTER Macrosito IT17-M Stazioni Di Ricerca In Antartide- Mooring A: Southwestern Ross Sea, Ross Island 44
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 44
The unfolded protein response: A novel therapeutic target in acute leukemias 43
Therapeutic targeting of mTOR in T-cell acute lymphoblastic leukemia: An update 43
New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia 43
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. 41
B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients? 41
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 40
GSK-3: a multifaceted player in acute leukemias 40
Phospholipase C-beta1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation. 40
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 38
Activity of the selective I?B kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a. 38
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 36
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment 36
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 35
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells 35
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 35
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 34
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies. 34
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 30
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 29
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 29
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 29
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene 29
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 29
Autophagy in acute leukemias: A double-edged sword with important therapeutic implications 27
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 27
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 26
Current treatment strategies for inhibiting mTOR in cancer 25
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 25
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response 25
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 25
PLCbeta1a and PLCbeta1b selective regulation and cyclin D3 modulation reduced by Kinamycin F during K562 cell differentiation. 24
Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients 24
K562 cell proliferation is modulated by PLC beta 1 through a PKC alpha-mediated pathway 24
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; Indications for novel therapeutics 23
Totale 2.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.138
article - articoli 6.878
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 260
Totale 14.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 1 0 0 1
2024/2025944 7 2 64 33 273 67 11 61 33 13 201 179
2025/20261.267 96 142 96 260 210 55 177 58 54 72 47 0
Totale 2.213